Robert Giugliano, MD, SM, on the Effects of Ezetimibe Add-on Therapy Among Older Adults
In this podcast, Robert Giugliano, MD, SM, discusses his latest analysis of IMPROVE-IT data, which compared simvastatin-ezetimibe combination therapy with simvastatin monotherapy among patients aged 75 years or older who had had acute coronary syndrome. He also explains which patient groups benefitted the most from ezetimibe add-on therapy. More at: www.consultant360.com/cardiology.